Facet browsing currently unavailable
Page 5 of 2283 results
Sort by: relevance publication year
Increased Frequency of CpG Island Methylator Phenotype and CDH1 Methylation in a Gastric Cancer High-Risk Region of China JOURNAL ARTICLE published March 2008 in Translational Oncology |
Anti–Programmed Cell Death (PD)-1 Immunotherapy for Malignant Tumor: A Systematic Review and Meta-Analysis JOURNAL ARTICLE published February 2016 in Translational Oncology |
Therapeutic Targeting Cancer-Initiating Cell Markers by Exosome miRNA: Efficacy and Functional Consequences Exemplified for claudin7 and EpCAM JOURNAL ARTICLE published February 2019 in Translational Oncology Research funded by German Cancer Research Aid (110836) | China Scholarship Council (201608080054,201608080054) | German Cancer Research Aid (110836) |
Lymphocyte-Related Inflammation and Immune-Based Scores Predict Prognosis of Chordoma Patients After Radical Resection JOURNAL ARTICLE published April 2018 in Translational Oncology |
Diagnostic assessment of deep learning for melanocytic lesions using whole-slide pathological images JOURNAL ARTICLE published September 2021 in Translational Oncology Research funded by Chinese PLA General Hospital (2018TM-10) |
Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis JOURNAL ARTICLE published August 2022 in Translational Oncology Research funded by National Natural Science Foundation of China (82,173,177) |
Induction Chemotherapy Has No Prognostic Value in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Chronic Hepatitis B Infection in the IMRT Era JOURNAL ARTICLE published October 2017 in Translational Oncology |
Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer JOURNAL ARTICLE published August 2015 in Translational Oncology |
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma JOURNAL ARTICLE published May 2024 in Translational Oncology |
Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis JOURNAL ARTICLE published October 2016 in Translational Oncology |
GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation JOURNAL ARTICLE published January 2024 in Translational Oncology |
Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images JOURNAL ARTICLE published January 2021 in Translational Oncology |
Exposure to Tobacco Smoking Induces a subset of Activated Tumor-resident Tregs in Non-Small Cell Lung Cancer JOURNAL ARTICLE published January 2022 in Translational Oncology Research funded by National Natural Science Foundation of China (81802823) | Fundamental Research Funds for the Central Universities (20720190101) |
Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors JOURNAL ARTICLE published September 2023 in Translational Oncology |
Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines JOURNAL ARTICLE published May 2021 in Translational Oncology |
Cutaneous Angiosarcoma of Head and Neck: A New Predictive Score for Locoregional Metastasis JOURNAL ARTICLE published June 2015 in Translational Oncology |
The clinical application of 68Ga-PSMA PET/CT and regulating mechanism of PSMA expression in patients with brain metastases of lung cancer JOURNAL ARTICLE published February 2023 in Translational Oncology |
KIAA1529 regulates RAD51 expression to confer PARP inhibitors resistance in ovarian cancer JOURNAL ARTICLE published October 2022 in Translational Oncology |
G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells JOURNAL ARTICLE published July 2023 in Translational Oncology Research funded by US Department of Defense (W81XWH2110903) | National Institutes of Health (R01-CA211875,R01CA234025,R03CA223709) |
miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway JOURNAL ARTICLE published February 2024 in Translational Oncology |